Status:
COMPLETED
Contrast Enhanced Intraoperative Ultrasound for Detection and Characterization of Renal Mass Undergoing Open Partial Nephrectomy
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Kidney Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical research is to learn how effective an ultrasound contrast agent, called DEFINITY, is when used during ultrasound-guided surgery to remove part of one or both kidneys.
Detailed Description
DEFINITY is a contrast agent that is used to create better quality ultrasound images. On the day before or the day of the standard of care surgery, women who are able to become pregnant must have a n...
Eligibility Criteria
Inclusion
- Patients must have previous cross sectional imaging (CT or MRI) demonstrating renal mass or masses that is amenable to open partial nephrectomy.
- Patient is scheduled for intraoperative ultrasound guided open partial nephrectomy.
- Patient must sign informed consent, with risks and benefits of CEUS explained (see risks outlined on the following pages)
Exclusion
- Patients with known renal mass scheduled for total or laparoscopic partial nephrectomy.
- Patients who are hypersensitive to Definity (Perflutren Lipid Microsphere)
- Patients with known history of right-to-left, bidirectional or transient right-to-left cardiac shunts.
- Pediatric patients less than 18 years of age.
- Pregnant or nursing mothers.
Key Trial Info
Start Date :
October 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT01894607
Start Date
October 1 2013
Last Update
April 14 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas MD Anderson Cancer Center
Houston, Texas, United States, 77030